Matt Callahan, PhD
Matt Callahan joined The Column Group in 2024 after completing his PhD in Chemical Biology at UC San Francisco. His thesis work in the Gestwicki Lab explored a novel mode of molecular recognition by CHIP, a ubiquitin ligase implicated in neurodegenerative disease. Matt also gained exposure to biotech company creation while at UCSF, working with […]
Matt Callahan, PhD Read More »